Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cancer Genetics, Inc.
Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit has been filed on behalf of investors that purchased Cancer Genetics, Inc.
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cancer Genetics, Inc.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cancer Genetics, Inc.
Glancy Prongay & Murray LLP ("GPM") continues its investigation on behalf of Cancer Genetics, Inc.
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Cancer Genetics, Inc.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Cancer Genetics, Inc.
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018
LD Micro Main Event and Benchmark Micro Cap Conference
Founder of Multiple Successful Biotech Companies Including Actelion Pharmaceuticals, Sold to Johnson & Johnson for $30 Billion
Company Also Increased Number of Clinical Trials and Studies it Supports to 191, up 59%
